Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Shares Outstanding (2020 - 2025)

BioAtla's Shares Outstanding history spans 6 years, with the latest figure at $63.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 9.23% year-over-year to $63.5 million; the TTM value through Dec 2025 reached $63.5 million, up 9.23%, while the annual FY2025 figure was $63.5 million, 9.23% up from the prior year.
  • Shares Outstanding reached $63.5 million in Q4 2025 per BCAB's latest filing, up from $58.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $63.5 million in Q4 2025 to a low of $1.2 million in Q4 2022.
  • Average Shares Outstanding over 5 years is $35.6 million, with a median of $47.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: crashed 99.6% in 2024, then skyrocketed 30677.98% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $35.8 million in 2021, then tumbled by 96.61% to $1.2 million in 2022, then soared by 3866.93% to $48.1 million in 2023, then increased by 20.84% to $58.1 million in 2024, then grew by 9.23% to $63.5 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Shares Outstanding are $63.5 million (Q4 2025), $58.8 million (Q3 2025), and $58.7 million (Q2 2025).